Events
The first 18 months have been an exciting journey. Here are some of the major events and activities.
Core activities
Breakfast meetings
The core meeting point is the PRIMA Breakfast Meetings. Once a month the whole team meets to discuss and present science, and the first meeting was in November 2023.
Seminar
From groundbreaking research to innovation in academia and industry
The seminar was arranged in collaboration with UiO Growth House and Norwegian Society of Immunology. Speakers included David Humphreys, Executive Director, Head of Antibody and Novel Therapeutics, UCB Pharma, UK, and local speakers from UiO Growth House, Inven2, and Authera AS.
Science fair
PRIMA at "Forsknings-torget"
Photo: Åsne Rambøl Hillestad
Every fall the Medical Faculty at UiO organizes a public science fair at the Norwegian Museum of Science and Technology. PRIMA was in 2024 represented by an enthusiastic group of scientists and students, sharing their knowledge with the public and engaging visitors in games and activities. Immune Pokemon cards were some of the highlights.
Workshop
PRIMA workshop
Photo: Lise Kveberg
October 10, the whole PRIMA family gathered at Håndverkeren to engage in scientific presentations, discussions, and networking. The main topics for the workshop was discovering new immune targets, overcoming immune suppression, and development of new protein biologics.
Guest lectures
Dr. Michel Sadelain
Professor at Memorial Sloan Kettering Cancer Center MSKCC.
Keynote lecture: "CD19 CAR T cells: a new paradigm for immunotherapy”
Dr. John Haanen
Professor at Netherlands Cancer Institute NKI, Netherland
Keynote lecture; “On TIL and TCR-T”
Dr. Özlem Türeci
CMO BioNTech and Prof at Mainz University Medical Ctr & Helmholtz Institute for Translational Oncology, Germany
Keynote lecture: "RNA-based therapeutics and personalized neoantigen cancer vaccines"
Dr. Nebojsa Janjic
CSO at SomaLogic, US.
Guest lecture: "Synthetic antibody-like reagents made from DNA. Modified aptamers as a versatile tool for high-content proteomics"
Dr. Björn Frendeus
CSO BioInvent, Sweden.
Guest lecture: "Therapeutic Antibody Discovery and Development"
Dr. Magnus Essand
Prof of Gene Therapy, Uppsala University. Co-founder and Chief Scientific Officer of Elicera Therapeutics, Sweden
Guest lecture: "Arming CAR-T cells for potent bystander anti-tumor immune responses"
Dr. Anna Dimberg
Prof of Cancer and Vascular Biology, Uppsala University, Sweden.
Guest lecture: "Tailoring vascular phenotype to induce anti-tumor immunity"
Dr. Ronald Germain
Prof. Ronald Germain, NIH, US.
Guest lecture: "Visualizing Immunity – Insights from Multiplex Dynamic and Static Tissue-scale Imaging"
Dr. Stephen Beers
Prof of Immunology and Immunotherapy, University of Southampton, UK.
Guest lecture: "Impact of the Tumour Microenvironment and Host Factors on Responses to Antibody Therapy"
Dr. Gillian Griffith
Prof at the University of Cambridge, UK
Guest lecture: "The remarkable intracellular dynamics during CTL-mediated killing
Dr. Mark Cragg
Prof at the University of Southampton, UK.
Guest lecture: “Precision medicine and targeting in the era of immunotherapy”